The nation’s first hospice is located in Branford, Connecticut and on December, 20th they announced plans to study how medical marijuana can help dying patients. Representatives from Connecticut Hospice Inc. explained they hoped to improve pain management while also reducing opioid use in palliative care. The company says it has federal approval for its study and hopes to decrease nausea and vomiting while improving patients’ appetites and overall well-being among other things. St. Francis Hospital, which is also located in Connecticut, announced it received state approval to begin studying the effectiveness of medical marijuana as a painkiller for traumatic injuries.
Connecticut’s medical marijuana program enables research into the benefits of medical marijuana to be vetted by a new institutional review board and okayed by the state’s Department of Consumer Protection commissioner. Recently enabled state laws such as these should hopefully encourage more legalized states to conduct similar studies being done in Connecticut.
With 19 states currently selling recreational cannabis, it may be tempting to forgo a medical card, even if you qualify as a patient. While recreational marijuana is accessible in many states for those of age, there are still some benefits to having a medical marijuana card and purchasing medical marijuana instead of recreational pot. For…
A type of arthritis known as ‘gout’ is common, complex, and can affect anyone. Patients who suffer from gout are plagued by sudden and severe spikes of pain, swelling, and more. This condition affects certain joints but is often the joint at the base of the big toe. Gout is triggered by arthropathy which is…
In 1970 cannabis was federally placed as a Schedule I drug in the US, a category that is tightly restricted and reserved for drugs not medically accepted. When it comes to classifying drugs medically or recreationally, generally there are four broad categories according to the US federal government. Based on their properties and effects, a…
Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy. Cannabis and magic mushrooms for the win! According to recently published survey findings,…
In response to a significant increase in research on Schedule I controlled substances, the U.S. Drug Enforcement Administration (DEA) has proposed dramatically raised levels of legal cannabis and psychedelic production in 2022 for use in studies. After already increasing production quotas for 2021, the DEA is calling for a 60% increase in marijuana production. This…
Israeli cannabis company Tikun-Olam Cannbit has partnered with Israeli nutritional supplement company Ambrosia-SupHerb to produce and market a series of unique supplements…
We’ve all heard that cannabis has been around for thousands of years and used as an entheogen—a psychoactive substance used in a…
Since the coronavirus pandemic erupted in January 2020, researchers around the world have funneled their energy into carrying out virus-focused studies and…
